Aqua Bio Technology ASA
The answer first
Does Aqua Bio Technology beat the market?
No, Aqua Bio Technology has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 2% of Nordic stocks
- Quality2
- Value24
- Trend22
No. 185 of 195 in healthcare
Expectations in the price
Low expectations
For the share to return about 9% a year from today's price, it is enough that the cash Aqua Bio Technology keeps shrinks about 28% a year for 10 years.
Max for seven days
Follow Aqua Bio Technology with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Aqua Bio Technology
Your first answer is free, no account needed.
Do you own Aqua Bio Technology, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Aqua Bio Technology and a few more. Free, no card.
Super Stock+44.6%In short
- Aqua Bio Technology has fallen 82.2% over the past year, including dividends.
- Overall, Aqua Bio Technology ranks better than 2% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 98.8%. The price is 99.9% below its peak now.
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 2% of Nordic stocks.
No. 185 of 195 in healthcare
Low Weaker accounts than most: low profitability, high debt or uneven results.
No. 195 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.01
- Asset turnoverSales divided by everything the company owns0.01
- Return on equityProfit divided by equity−222.6%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 83 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity1.6
- P/SPrice divided by sales38.0
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
Low Headwind in the share price: it has done worse than most over the last year.
No. 120 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−14.2%
- 6 months−3.4%
- 9 months−49.5%
- 12 months−82.2%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About Aqua Bio Technology
Aqua Bio Technology ASA is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 2 employees.
Aqua Bio Technology ASA, together with its subsidiary, develops and sells ingredients for skin care products in Norway. The company offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. It also provides freight logistics solutions for trading companies. The company distributes its products through internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is headquartered in Oslo, Norway.


See the full analysis of Aqua Bio Technology.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card